THURSDAY, Dec. 21, 2023 (HealthDay News) — A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. A lab-made monoclonal antibody called omalizumab (Xolair) significantly increased the amounts of common foods that children could eat without sparking an allergic reaction, the U.S.Continue Reading

MONDAY, Nov. 13, 2023 (HealthDay News) — Climate change-driven hurricanes, floods and superstorms are threatening to create a surge in mold growth in people’s homes, sickening residents and robbing them of breath. Local hospitals witness a nearly twofold increase in diagnoses related to mold exposure following a storm-related natural disaster,Continue Reading

SATURDAY, Nov. 11, 2023 (HealthDay News) — The Thanksgiving table is typically loaded down with turkey, stuffing, gravy, mashed potatoes and all kinds of pie, but nutritionists say kids should also be encouraged to eat fresh fruit and vegetables during the holiday meal. Precious few children eat enough fruits andContinue Reading

TUESDAY, Oct. 3, 2023 (HealthDay News) — Some common medications — including antidepressants, sleep aids and painkillers — may dull the driving skills of seniors, a new study finds. Many different medication classes have been linked to the risk of driving impairment, as anyone who has ever read the labelContinue Reading

WEDNESDAY, Sept. 20, 2023 (HealthDay News) — In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray was widely anticipated. An FDA advisory panel votedContinue Reading